Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 11—November 2007
Research

Protection and Virus Shedding of Falcons Vaccinated against Highly Pathogenic Avian Influenza A Virus (H5N1)

Michael Lierz*Comments to Author , Hafez M. Hafez*, Robert Klopfleisch†, Dörte Lüschow*, Christine Prusas*, Jens P. Teifke†, Miriam Rudolf†, Christian Grund†, Donata Kalthoff†, Thomas C. Mettenleiter†, Martin Beer†, and Timm Harder†
Author affiliations: *Freie Universität, Berlin, Germany; †Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany;

Main Article

Table 1

Titers (log2) of hemagglutination-inhibiting antibodies against homologous influenza H5 antigen in 10 Gyr-Saker hybrid falcons after vaccination*

Falcon no., vaccination route Titer at 0–8 weeks after vaccination
0† 1 2 3 4‡ 5 6 7 8
1, IM 0 0 0 2 4 5 6 6 7
2, IM 0 0 0 2 3 4 6 8 9
3, IM 0 0 0 2 5 6 7 8 8
4, IM 0 0 0 3 4 4 6 7 6
5, IM 0 0 0 0 0 0 3 3 3
6, SC 0 0 0 3 4 5 6 8 7
7, SC 0 0 0 2 3 4 6 8 7
8, SC 0 0 0 3 3 4 5 6 7
9, SC 0 0 0 2 4 6 6 7 7
10, SC 0 0 0 3 4 5 6 6 6

*Vaccination with an inactivated influenza (H5N2) vaccine (strain A/duck/Potsdam/1402/86) at a dose of 0.5 mL containing >4 log2 hemagglutinating units. IM, intramuscular; SC, subcutaneous.
†Time of first vaccination.
‡Time of booster vaccination.

Main Article

Page created: July 06, 2010
Page updated: July 06, 2010
Page reviewed: July 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external